 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Journal: A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants. (Pubmed Central) - Aug 27, 2024
We generate an intranasal live-attenuated SARS-CoV-2 vaccine, CDO-7N-1, using codon deoptimization...Antibody responses are sustained and enhanced by repeated immunization or infection with WT SARS-CoV-2. Immunity against all SARS-CoV-2 proteins by CDO-7N-1 should improve efficacy against future SARS-CoV-2 variants.
- | Live Attenuated SARS – CoV-2 Vaccine / Indian Immunologicals, Griffith University
Journal: Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic? (Pubmed Central) - Sep 29, 2022
Immunity against all SARS-CoV-2 proteins by CDO-7N-1 should improve efficacy against future SARS-CoV-2 variants. No abstract available